Inferensys

Glossary

Binding Affinity

The quantitative strength of the non-covalent interaction between a single biomolecule, typically a protein, and its ligand, usually expressed via thermodynamic dissociation or inhibition constants.
Stylish WeWork-like workspace with hot desks and document wall, professional searching through enterprise knowledge base on a mounted ultrawide display, warm industrial pendants overhead.
THERMODYNAMIC CONSTANT

What is Binding Affinity?

Binding affinity quantifies the strength of the reversible, non-covalent interaction between a biomolecule, typically a protein, and its ligand.

Binding affinity is the quantitative measure of the strength of the interaction between a single biomolecule and its ligand, expressed through the equilibrium dissociation constant (Kd) or inhibition constant (Ki). A lower Kd value signifies a higher, tighter binding affinity, reflecting a greater proportion of occupied target protein at a given ligand concentration.

This thermodynamic parameter is governed by the Gibbs free energy change (ΔG) of binding, which is the sum of enthalpic contributions from hydrogen bonds and van der Waals contacts, and entropic changes from the displacement of ordered water molecules. Accurate prediction of binding affinity is the central objective of drug-target interaction modeling, directly correlating with a compound's in vivo efficacy and driving the prioritization of lead candidates in virtual screening campaigns.

THERMODYNAMIC AND KINETIC FOUNDATIONS

Core Characteristics of Binding Affinity

Binding affinity quantifies the strength of a non-covalent interaction between a biomolecule and its ligand. It is governed by a delicate interplay of enthalpic and entropic contributions, expressed through equilibrium constants and free energy landscapes.

01

The Thermodynamic Dissociation Constant (Kd)

The dissociation constant (Kd) is the gold-standard measure of affinity, representing the ligand concentration at which half the target's binding sites are occupied. A lower Kd indicates higher affinity.

  • Formula: Kd = [P][L] / [PL]
  • Units: Molar (M), typically ranging from mM (weak) to pM (ultra-tight)
  • Relationship: Kd is the reciprocal of the association constant (Ka)
  • Measurement: Determined via Surface Plasmon Resonance (SPR), Isothermal Titration Calorimetry (ITC), or radioligand binding assays
  • Example: Biotin-streptavidin complex exhibits a Kd of ~10⁻¹⁴ M, one of the strongest known non-covalent interactions
10⁻³ to 10⁻¹⁴ M
Typical Kd Range
02

Gibbs Free Energy of Binding (ΔG)

The Gibbs free energy change (ΔG) upon binding determines spontaneity and is directly related to Kd. A more negative ΔG signifies a more favorable, higher-affinity interaction.

  • Equation: ΔG = -RT ln(Ka) = RT ln(Kd)
  • Components: ΔG = ΔH - TΔS, where ΔH is enthalpy change and ΔS is entropy change
  • Energy Scale: A ΔG of -10 kcal/mol corresponds to a Kd of ~50 nM at 298 K
  • Enthalpy-Driven: Dominated by favorable hydrogen bonds, van der Waals contacts, and electrostatic interactions
  • Entropy-Driven: Driven by the hydrophobic effect and release of ordered water molecules from the binding interface
-5 to -15 kcal/mol
Typical Drug Binding ΔG
03

Enthalpy-Entropy Compensation

Enthalpy-entropy compensation is the observed phenomenon where favorable enthalpic gains from forming intermolecular bonds are often offset by unfavorable entropic losses from conformational restriction, and vice versa.

  • Mechanism: Stronger binding interactions (favorable ΔH) rigidify the complex (unfavorable -TΔS)
  • Solvent Reorganization: Release of structured water from hydrophobic surfaces is entropically favorable but enthalpically neutral or slightly unfavorable
  • Drug Design Implication: Optimizing for enthalpy-driven binders often yields higher selectivity, as entropic contributions from desolvation are less target-specific
  • ITC Deconvolution: Isothermal Titration Calorimetry uniquely measures ΔH and ΔS independently, revealing the thermodynamic signature of binding
04

Kinetics: Association and Dissociation Rates

Binding affinity is a ratio of kinetic rate constants. The association rate (kon) and dissociation rate (koff) define how quickly a complex forms and decays, with Kd = koff / kon.

  • kon: Diffusion-limited maximum ~10⁸ to 10⁹ M⁻¹s⁻¹; influenced by electrostatic steering and conformational selection
  • koff: Ranges from milliseconds (weak binders) to days (tight binders); the primary determinant of residence time
  • Residence Time (τ): τ = 1/koff; often correlates better with in vivo efficacy than Kd alone
  • SPR Biosensors: Surface Plasmon Resonance provides real-time kon and koff measurements without labels
  • Clinical Relevance: Drugs with long residence times (slow koff) can maintain target engagement even after plasma clearance
τ = 1/koff
Residence Time Formula
05

The Role of Solvation and Desolvation

Desolvation is the energetic cost of stripping water molecules from the binding interfaces of both protein and ligand before complex formation. This process profoundly influences the net binding free energy.

  • Hydrophobic Effect: Burial of non-polar surface area releases ordered water into bulk solvent, providing a favorable entropic driving force
  • Polar Desolvation Penalty: Removing water from charged or polar groups is energetically costly and must be compensated by new hydrogen bonds in the complex
  • Water Networks: Structured water molecules bridging protein and ligand can contribute favorably to binding enthalpy if optimally positioned
  • Computational Prediction: Implicit solvation models (GBSA, PBSA) approximate these effects, while explicit solvent molecular dynamics provide detailed water maps
06

IC50 and EC50: Functional Affinity Measures

IC50 (half-maximal inhibitory concentration) and EC50 (half-maximal effective concentration) are functional measures of a compound's potency, which depend on both binding affinity and downstream cellular context.

  • IC50: Concentration required to inhibit a biological process by 50%; commonly used in enzyme and cell-based assays
  • EC50: Concentration producing 50% of the maximal response; used for agonists and activators
  • Cheng-Prusoff Equation: Relates IC50 to Ki (inhibition constant) for competitive inhibitors: Ki = IC50 / (1 + [S]/Km)
  • Assay Dependency: IC50 values vary with substrate concentration, incubation time, and cell type, unlike the system-independent Kd
  • Caution: IC50 is not a direct measure of binding affinity; it conflates target engagement with functional pathway amplification
Ki = IC50 / (1 + [S]/Km)
Cheng-Prusoff Correction
BINDING AFFINITY EXPLAINED

Frequently Asked Questions

Explore the fundamental thermodynamic and kinetic principles governing the strength of interaction between a biomolecule and its ligand, and how these concepts are computationally modeled in modern drug discovery.

Binding affinity is the quantitative strength of the non-covalent interaction between a single biomolecule (typically a protein) and its ligand (a small molecule or another biomolecule). It is formally defined by the equilibrium dissociation constant, K<sub>d</sub>, which represents the ligand concentration at which half of the available binding sites are occupied at equilibrium. A lower K<sub>d</sub> value indicates a higher affinity, with values often ranging from millimolar (10<sup>-3</sup> M, weak) to picomolar (10<sup>-12</sup> M, extremely tight). The relationship is thermodynamic: the Gibbs free energy of binding (ΔG) is related to K<sub>d</sub> by the equation ΔG = RT ln(Kd), where R is the gas constant and T is the absolute temperature. Alternative metrics include the inhibition constant (K<sub>i</sub>) for competitive inhibitors and the half-maximal inhibitory concentration (IC<sub>50</sub>), though the latter is assay-dependent and not a true thermodynamic constant.

COMPARATIVE METROLOGY

Binding Affinity vs. Related Metrics

A comparison of binding affinity with other quantitative measures used to characterize drug-target interactions and pharmacological potency.

MetricBinding AffinityScoring FunctionIC50 / EC50Residence Time

Primary Definition

Thermodynamic strength of a single non-covalent binding event

Mathematical approximation of binding free energy for pose ranking

Concentration of drug required for 50% inhibition or effect in a functional assay

Average duration a ligand remains bound to its target

Fundamental Unit

Kd, Ki, or ΔG (kcal/mol)

Arbitrary score or estimated ΔG (kcal/mol)

Molar concentration (nM, μM)

Time (seconds, minutes)

Measurement Context

Biophysical assay (SPR, ITC, MST)

Computational (in silico)

Biochemical or cell-based functional assay

Biophysical kinetic assay (SPR, stopped-flow)

Captures Kinetics

Reflects In Vivo Efficacy

Directly Measured

Typical Use in Drug Discovery

Hit triage and lead optimization

Virtual screening and pose prediction

Potency ranking and SAR analysis

Optimization of target occupancy duration

Thermodynamic Parameter

ΔG, ΔH, ΔS

Estimated ΔG only

Activation energy (ΔG‡) for dissociation

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.